Reversal of liver cirrhosis: current evidence and expectations
Young Kul Jung, Hyung Joon Yim
Korean J Intern Med. 2017;32(2):213-228.   Published online 2017 Feb 8     DOI:
Citations to this article as recorded by Crossref logo
Lipophagy and liver disease: New perspectives to better understanding and therapy
Zili Zhang, Zhen Yao, Yifan Chen, Lei Qian, Shuoyi Jiang, Jingyi Zhou, Jiangjuan Shao, Anping Chen, Feng Zhang, Shizhong Zheng
Biomedicine & Pharmacotherapy.2018; 97: 339.     CrossRef
Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B
D.-P. Liu, W. Lu, Z.-Q. Zhang, Y.-B. Wang, R.-R. Ding, X.-L. Zhou, D. Huang, X.-F. Li
Journal of Viral Hepatitis.2018;[Epub]     CrossRef
Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C
Ali Afsari, Edward Lee, Babak Shokrani, Tina Boortalary, Zaki A. Sherif, Mehdi Nouraie, Adeyinka O. Laiyemo, Kawtar Alkhalloufi, Hassan Brim, Hassan Ashktorab
Digestive Diseases and Sciences.2017; 62(8): 2159.     CrossRef
Metabolomic profiling for identification of metabolites and relevant pathways for taurine in hepatic stellate cells
Xin Deng, Xing-Qiu Liang, Fei-Guo Lu, Xiao-Fang Zhao, Lei Fu, Jian Liang
World Journal of Gastroenterology.2017; 23(31): 5713.     CrossRef
Cellular senescence and liver disease: Mechanisms and therapeutic strategies
Mei Guo
Biomedicine & Pharmacotherapy.2017; 96: 1527.     CrossRef